Schnyder Corneal Dystrophy Treatment & Management

Updated: Jun 10, 2020
  • Author: Ahmed Farghaly Abdelhameed Omar, MD, PhD; Chief Editor: Hampton Roy, Sr, MD  more...
  • Print
Treatment

Medical Care

No local or systemic medical treatment is available to stop the progression of corneal lipid deposition or the alteration of serum cholesterol levels.

Next:

Surgical Care

Penetrating keratoplasty (PKP) can be performed successfully in those patients with advanced disease, but the dystrophy can recur in the graft. One study showed recurrence in 21% of eyes who underwent PKP. [3]

Phototherapeutic keratectomy can remove subepithelial crystals if they are causing decreased vision and glare, but it does not reduce panstromal haze. [6]

Previous
Next:

Long-Term Monitoring

Patients should receive follow-up care as needed.

Previous